With operations across the United States, China, and Europe and by integrating technology with medicine, this company stands as a leading biopharmaceutical organization. Specializing in the discovery, manufacture, and commercialization of innovative cell therapies, it addresses diseases previously deemed incurable, enhancing patient care and outcomes.
Recognizing the pivotal role of user experience in today’s digital landscape, the company has committed to a comprehensive website redesign, striving to ensure that each interaction with its online platform is intuitive, seamless, and ultimately satisfying for its customers.
The company chose Brillio as its strategic partner to develop a comprehensive roadmap for the website overhaul. The scope of work included integrating new functionalities, updating content, modernizing layouts, and optimizing navigation to augment the business’s online presence and customer engagement.
Following an extensive analysis of the client’s ecosystem, a roadmap and solution approach were developed, featuring a twofold strategy: a complete website redesign and migration to a highly scalable, maintainable, and cost-efficient Content Management System (CMS).
The new CMS would leverage WordPress for its exceptional capabilities in seamless content creation and management. This intuitive CMS was designed to reduce non-technical staff’s reliance on IT support, streamlining content publishing and enabling swift transitions from concept development to testing and production. Consequently, resources and time allocated to content management would be significantly reduced, facilitating agile and efficient operations.
Implementing a streamlined CMS would reduce technology expenses and empower the organization to consolidate its operations into a single, centralized platform, expediting time-to-market for new initiatives. AWS was chosen as the optimal solution for cloud deployment of the CMS, specifically recommending deployment on an AWS EC2 instance.
